Welcome to Helix Talk, an educational podcast for healthcare students and providers covering real-life clinical pearls, professional pharmacy topics, and drug therapy discussions.

This podcast is provided by pharmacists and faculty members at Rosal Franklin University College of Pharmacy.

This podcast contains general information for educational purposes only. This is not

professional advice and should not be used in lieu of obtaining advice from a qualified

health care provider. And now on to the show. Welcome to Helix Talk episode 132. I'm your

co-host Dr. Kane. And I'm Dr. Patel. And in this episode, titled the War Up Speed of

COVID-19 Vaccine Authorization, Timeline and Discussion with Dr. Urchin Achadji. We explore the history of

the COVID-19 vaccine development and kind of have a heart-to-heart conversation with our very own Dr.

Arjuna-Gh, more so diving into her role as the dean of Chicago Medical School, her career

path, and her positions and functions on the FDA's vaccine and related biological products

advisory committee. We know that nowadays as work pack.

Dr. Patel, we haven't really covered a lot of the data specific to COVID-19 vaccines,

mostly because it's been well covered and a lot of other resources out there.

We did talk about EUAs in episode 124.

That would be emergency use authorizations.

But we decided that there is a role at this point,

we're more than a year out of COVID-19 pandemic.

It is nice to kind of look back and think about the timeline of where things have gone from,

you know, back into December 2019 all the way to today and really how fast

things have really developed. And as we'll talk about with Dr. Chatterjee, the role of that

committee in approving these MRNA and other vaccines for COVID-19. Yeah. And so to jump right

into it, Dr. Kane, you know, as we mostly, everybody knows,

...